Adler Michael, Schulz Sven, Fischer Renate, Niemeyer Christof M
Chimera Biotec GmbH, Emil-Figge-Str. 76 A, D-44227 Dortmund, Germany.
Biochem Biophys Res Commun. 2005 Aug 12;333(4):1289-94. doi: 10.1016/j.bbrc.2005.06.027.
Immuno-PCR (IPCR) has been studied to increase the detection sensitivity of current enzyme-linked immuno-sorbent assays (ELISA) as a novel approach for the early detection of Rotavirus infection, a major source for serious diarrhoea for susceptible risk groups. IPCR utilizes specific antibody-DNA conjugates with subsequent amplification of the marker-DNA. An antibody-DNA conjugate specific for Rotavirus antigen VP6 was synthesized and used in combination with a commercially available Rotavirus-ELISA kit. IPCR was carried out using reagents and protocols of the standardized Imperacer system. Real-time PCR monitoring of the marker-DNA amplification was compared to endpoint quantification of amplified haptene-labeled PCR products, using a microtiterplate-based PCR-ELISA. In spiked calibration samples, as few as 100 virus particles/ml could be clearly detected using the IPCR method and either real-time or end-point quantification compared to about 100,000 virus particles/ml in ELISA. Rotavirus positive and negative stool samples were correctly identified by IPCR with a clear separation even of a 10,000-fold dilution of the positive stool samples from the negative control.
免疫聚合酶链反应(IPCR)作为一种用于早期检测轮状病毒感染的新方法,已被研究用于提高当前酶联免疫吸附测定(ELISA)的检测灵敏度,轮状病毒感染是易感风险人群严重腹泻的主要来源。IPCR利用特异性抗体 - DNA缀合物,随后对标记DNA进行扩增。合成了一种针对轮状病毒抗原VP6的抗体 - DNA缀合物,并与市售的轮状病毒ELISA试剂盒联合使用。IPCR使用标准化的Imperacer系统的试剂和方案进行。使用基于微孔板的PCR - ELISA,将标记DNA扩增的实时PCR监测与扩增的半抗原标记PCR产物的终点定量进行比较。在加标的校准样品中,与ELISA中约100,000个病毒颗粒/毫升相比,使用IPCR方法以及实时或终点定量法,每毫升低至100个病毒颗粒都能被清晰检测到。IPCR能够正确识别轮状病毒阳性和阴性粪便样本,即使将阳性粪便样本稀释10,000倍,与阴性对照也能明显区分开来。